首页> 外国专利> RECOMBINANT PLASMID DNA HIV 24-5, ENCODING FUSED PROTEIN OF HEPATITIS B VIRUS CORE-ANTIGEN AND ENVELOPE PROTEIN OF HUMAN IMMUNODEFICIENCY VIRUS, AND STRAIN OF BACTERIA ESCHERICHIA COLI - A PRODUCER OF FUSED PROTEIN OF HEPATITIS B VIRUS CORE-ANTIGEN AND ENVELOPE PROTEIN OF HUMAN IMMUNIDEFICIENCY VIRUS

RECOMBINANT PLASMID DNA HIV 24-5, ENCODING FUSED PROTEIN OF HEPATITIS B VIRUS CORE-ANTIGEN AND ENVELOPE PROTEIN OF HUMAN IMMUNODEFICIENCY VIRUS, AND STRAIN OF BACTERIA ESCHERICHIA COLI - A PRODUCER OF FUSED PROTEIN OF HEPATITIS B VIRUS CORE-ANTIGEN AND ENVELOPE PROTEIN OF HUMAN IMMUNIDEFICIENCY VIRUS

机译:重组质粒DNA HIV 24-5,编码乙型肝炎病毒核心抗原和人免疫缺陷病毒包膜蛋白的融合蛋白,以及产肠埃希氏菌的细菌-肝癌B蛋白和蛋白融合蛋白的生产者。免疫缺陷病毒

摘要

the invention u043eu0442u043du043eu0441u0438u0442u0441u00a0 to the microbiological and medical industry and biotechnology. purpose u0438u0437u043eu0431u0440u0435u0442u0435u043du0438u00a0 u00a0u0432u043bu00a0u0435u0442u0441u00a0 u043fu043eu043bu0443u0447u0435u043du0438u0435u0431u0435u043bu043au0430 with immune boosting gene activity in the u044du043du0442u0438u0433u0435u043du0430u0438 virus hepatitis b and virus protein shell u0438u043cu043cu0443u043du043eu0438u0437u043eu0431u0440u0435u0442u0435u043du0438u0435 from u043du043eu0441u0438u0442u0441u00a0 to the microbiological and medical industry and biotechnology.purpose to obtain u0438u0437u043eu0431u0440u0435u0442u0435u043du0438u00a0 u00a0u0432u043bu00a0u0435u0442u0441u00a0 protein with u0438u043cu043cu0443u043du043eu0433u0435u043du043du043eu0439 activity in hepatitis b virus antigen and protein of the human immunodeficiency virus man as well. designed u0440u0435u043au043eu043cu0431u0438u043du0430u043du0442u043du0430u00a0 u043fu043bu0430u0437u043cu0438u0434u043du0430u00a0 dna u0441u043eu0441u0442u043eu00a0u0449u0430u00a0 the following elements: the lack of rights.the invention u043fu043eu0437u0432u043eu043bu00a0u0435u0442 get u0441u043bu0438u0442u044bu0439 protein u043du0432u0441u0430u0434, u0441u043eu0441u0442u043eu00a0u0449u0438u0439 of 114 n end amino acids in virus hepatitis b antigen (ddp) and full u0430u043cu0438u043du043eu043au0438u0441u043bu043eu0442u043du043eu0439 u043fu043eu0441u043bu0435u0434u043eu0432u0430 u044024) protein of human immunodeficiency virus (hiv). these proteins possess immunological activity as u043du0432u0441u0430u0434, and protein u044024 hiv.in addition to 144 amino acids u043du0432u0441u0430u0434 recombinant protein u043du0432u0441u0430u0434 AHIVp24 contains the following sequences of gag gene of hiv: 13 amino acid protein u044017, 231 amino acids u044024 and 74 amino acid u044015.protein synthesis u0440u0435u043au043eu043cu0431u0438u043du0430u043du0442u043du0430u00a0 encodes u043fu043bu0430u0437u043cu0438u0434u0430 pHIV 24 - 5, u043au043eu0442u043eu0440u0430u00a0 consists of dna plasmids u0440u043du0432u0441u0431 with gene u043du0432u0441u0430u0434 with optimized site initiation u0442u0440u0430u043du0441u043bu00a0u0446u0438u0438 and with u0442u0435u0440u043cu0438u043du0438u0440u0443u044eu0449u0438u043c u043au043eu0434u043eu043du043eu043c to 144. u0430u043cu0438u043du043eu043au0438u0441u043bu043eu0442u0435 gene, and a fragment of the genome of hiv, cloned in u043fu043bu0430u0437u043cu0438u0434u0435 u0440u0432u043du044e and the consistency between sites Pvull and restriction in the Bglll gag. the size of the plasmid 7900 sukhoy., u043cu043eu043b.u043c. 5.06 mda gene u044bu0430 provides resistance plasmids to u0430u043cu043fu0438u0446u0438u043bu043bu0438u043du0443. the gene u043du0432u0441u0430u0434 dr. HIVp24 u043du0430u0445u043eu0434u0438u0442u0441u00a0 under control of tandem u043fu0440u043eu043cu043eu0442u043eu0440u043eu0432 u0442u0440u0438u043fu0442u043eu0444u0430u043du043eu0432u043eu0433u043e u043eu043fu0435u0440u043eu043du0430. 2 p.s - lu, 2 table u0440u043du0432u04415 dna plasmids, u043au043eu0442u043eu0440u0430u00a0 u00a0u0432u043bu00a0u0435u0442u0441u00a0 u0440u043du0432u0441u0437 derivative plasmids with gene u043du0432u0441u0430u0434 with optimized site initiation u0442u0440u0430u043du0441u043bu00a0u0446u0438u0438, but with u0443u043au043eu0440u043eu0447u0435u043du043du044bu043c the u043du0430u0441u0430u0434 deprived of 39 n end amino acids and with a unique restriction site EcoRI no. 144. u0430u043cu0438u043du043eu043au0438u0441u043bu043eu0442u0435 gene u043fu0440u043eu0442u00a0u0436u0435u043du043du043eu0441u0442u044cu044e 6700 sukhoy., a fragment of the genome of human immunodeficiency virus (hiv), cloned in u043fu043bu0430u0437u043cu0438u0434u0435 u0440u0432u043du044e, the u043fu043eu0441u043bu0435XI sl u043fu0448u0434 yu to yu
机译:本发明是针对微生物和医学工业以及生物技术的 u043e u0442 u043d u043e u0441 u0438 u0442 u0441 u00a0。目的 u0438 u0437 u043e u0431 u0440 u0435 u0442 u0435 u043d u043d u0438 u00a0 u00a0 u0432 u043b u00a0 u0435 u0442 u0441 u00a0 u043f u043e u043b u044 u0435 u043d u0438 u0435 u0431 u0435 u043b u043a u0430在 u044d u043d u0442 u0438 u0433 u0435 u043d u0430 u0438病毒B和病毒蛋白外壳中具有免疫增强基因活性u0438 u043c u043c u0443 u043d u043e u0438 u0437 u043e u0431 u0431 u0440 u0435 u0442 u0435 u043d u043d u0438 u0435从 u043d u043e u0441 u0441 u0438 u0442 u0442 u0441微生物和医学工业及生物技术。目的是使用以下方法获得 u0438 u0437 u043e u0431 u0440 u0435 u0442 u0435 u043d u0438 u00a0 u00a0 u0432 u043b u00a0 u0435 u0442 u0441 u0040 u0438 u043c u043c u0443 u043d u043e u0433 u0435 u043d u043d u043d u043e u0439在乙型肝炎病毒抗原和人类免疫缺陷病毒男人的蛋白质中的活性也是如此。设计了 u0440 u0435 u043a u043e u043c u0431 u0438 u043d u0430 u043d u0442 u043d u0430 u00a0 u043f u043b u0430 u0437 u043c u0438 u0434 u043d u0430 00 u0441 u043e u0441 u0442 u043e u00a0 u0449 u0430 u00a0以下元素:缺少权限。发明 u043f u043e u0437 u0432 u043e u043b u00a0 u0435 u0442得到 u0441乙型肝炎病毒114个n末端氨基酸的蛋白 u043b u0438 u0442 u044b u0439蛋白 u043d u0432 u0441 u0430 u0434, u0441 u043e u0441 u0442 u0432 u043e u00a0 u0449 u0449 u0438 u0439抗原(ddp)和完整的 u0430 u043c u0438 u043d u043e u043a u0438 u0441 u043b u043e u0442 u043d u043e u0439 u043f u043e u0441 u0441 u043b u0435 u0434 u043e u0432人免疫缺陷病毒(hiv)的蛋白质。这些蛋白质除了具有144个氨基酸 u043d u0432 u0441 u0430 u0434重组蛋白 u043d u0432 u0441 u0430 u0434的免疫活性外,还具有 u043d u0432 u0441 u0430 u0434的免疫活性。 u0434 AHIVp24包含以下hiv gag基因序列:13个氨基酸 u044017、231个氨基酸 u044024和74个氨基酸 u044015。蛋白质合成 u0440 u0435 u043a u043e u043c u0431 u0438 u043d u0430 u043d u0442 u043d u0430 u00a0编码 u043f u043b u0430 u0437 u043c u0438 u0434 u0430 pHIV 24-5, u043a u043e u0442 u043e u0440 u0430 u00a0包含dna具有优化位点起始 u043d u0432 u0441 u0430 u0434基因的质粒 u0440 u043d u0432 u0441 u0431,具有优化的位点起始 u0442 u0440 u0430 u043d u0441 u043b u0040 u04a u0430 u043d u0438 u0442 u0435 u0440 u043c u0438 u043d u0438 u0440 u0443 u044e u0449 u0438 u043c u043a u043e u0434 u043e u043d u043e u043c u043c至144. u0430 u043c u043c u0438 u043e u043a u0438 u0441 u043b u043e u0442 u0435基因和一个碎片克隆到 u043f u043b u0430 u0437 u043c u0438 u0434 u0435 u0440 u0432 u043d u044e中的位点之间的一致性以及Bglll gag中限制性酶切位点之间的一致性。质粒7900 sukhoy的大小, u043c u043e u043b。 5.06 mda基因 u044b u0430为 u0430 u043c u043f u0438 u0446 u0438 u043b u043b u0438 u043d u0443提供抗性质粒。基因 u043d u0432 u0441 u0430 u0434 dr。 HIVp24 u043d u0430 u0445 u043e u0434 u0438 u0442 u0441 u00a0受串联 u043f u0440 u043e u043c u043e u0442 u043e u0440 u043e u0432 u0442 u043e u0440 u043e u0432 u043f u0442 u043e u0444 u0430 u043d u043e u0432 u043e u0433 u043e u043e u043f u0435 u0435 u0440 u043e u043d u0430。 2 ps-lu,2个表 u0440 u043d u0432 u04415 dna质粒, u043a u043e u0442 u043e u0440 u0430 u00a0 u00a0 u0432 u043b u00a0 u0435 u0442 u0441 u00a0 u40a u043d u0432 u0441 u0437具有基因 u043d u0432 u0441 u0430 u0434的衍生质粒,具有优化的位点起始 u0442 u0440 u0430 u043d u043d u0441 u043b u00a0 u0446 u0438 u0438 u0443 u043a u043e u0440 u043e u0447 u0435 u043d u0430 u0441 u0430 u0434缺少39 n个末端氨基酸,并且具有唯一的限制性位点EcoRI。 144. u0430 u043c u0438 u043d u043e u043a u0438 u0441 u043b u043e u0442 u0435基因 u043f u0440 u043e u0442 u00a0 u0436 u0435 u043d u043d u043e u0431 u0442 u044c u044e 6700 sukhoy。,人类免疫缺陷病毒(hiv)的基因组片段,克隆到 u043f u043b u0430 u0437 u043c u0438 u0434 u0435 u0440 u0432 u043d u044e u043f u043e u0441 u043b u0435XI sl u043f u0448 u0434 yu to yu

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号